Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monotherapy antiplatelet comparison after dual antiplatelet therapy in stent-assisted coil embolization for unruptured intracranial aneurysm
KCT0011419Phase 4Recruiting
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel and aspirin in brain aneurysm (IA) (2 arms), sponsored by Samjin Pharmaceutical Co., Ltd. Started Jun 2026; status: recruiting.
02
Drugs
clopidogrelaspirin
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on KCT0011419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011419.